CAR-T cells based on a TCR mimic nanobody targeting HPV16 E6 exhibit antitumor activity against cervical cancer. - Duan Z; Li D; Li N; Lin S; Ren H; Hong J; Hinrichs CS; Ho M (Molecular therapy. Oncology, 2024)